| Condition | Indicated | Relationship Strength | Studies | Trials |
|---|
Koch's Disease
[description not available] | 0 | 1.93 | 1 | 0 |
Pulmonary Consumption
[description not available] | 0 | 1.93 | 1 | 0 |
Tuberculosis
Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS. | 0 | 1.93 | 1 | 0 |
Tuberculosis, Pulmonary
MYCOBACTERIUM infections of the lung. | 0 | 1.93 | 1 | 0 |
Acute Disease
Disease having a short and relatively severe course. | 0 | 2.02 | 1 | 0 |
Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
[description not available] | 0 | 3.79 | 2 | 0 |
Hepatitis C
INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. | 0 | 3.79 | 2 | 0 |
Chronic Hepatitis C
[description not available] | 0 | 3.81 | 2 | 0 |
Hepatocellular Carcinoma
[description not available] | 0 | 4.1 | 3 | 0 |
Cancer of Liver
[description not available] | 0 | 4.1 | 3 | 0 |
Carcinoma, Hepatocellular
A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. | 0 | 4.1 | 3 | 0 |
Liver Neoplasms
Tumors or cancer of the LIVER. | 0 | 4.1 | 3 | 0 |
Hepatitis C, Chronic
INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS. | 0 | 3.81 | 2 | 0 |
Disease Exacerbation
[description not available] | 0 | 2.93 | 1 | 0 |
Cirrhosis
[description not available] | 0 | 2.93 | 1 | 0 |
Cirrhosis, Liver
[description not available] | 0 | 3.79 | 2 | 0 |
Fibrosis
Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury. | 0 | 2.93 | 1 | 0 |
Liver Cirrhosis
Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. | 0 | 8.79 | 2 | 0 |
Liver Steatosis
[description not available] | 0 | 2.93 | 1 | 0 |
Insulin Sensitivity
[description not available] | 0 | 2.93 | 1 | 0 |
Fatty Liver
Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS. | 0 | 2.93 | 1 | 0 |
Hepatitis
INFLAMMATION of the LIVER. | 0 | 4.69 | 2 | 1 |
Insulin Resistance
Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. | 0 | 2.93 | 1 | 0 |
Obesity
A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY). | 0 | 2.93 | 1 | 0 |
Chronic Illness
[description not available] | 0 | 3.76 | 2 | 1 |
Chronic Disease
Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). | 0 | 3.76 | 2 | 1 |
Hepatic Failure
[description not available] | 0 | 3.37 | 1 | 1 |
Liver Failure
Severe inability of the LIVER to perform its normal metabolic functions, as evidenced by severe JAUNDICE and abnormal serum levels of AMMONIA; BILIRUBIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASES; and albumin/globulin ratio. (Blakiston's Gould Medical Dictionary, 4th ed) | 0 | 3.37 | 1 | 1 |
Recrudescence
[description not available] | 0 | 1.98 | 1 | 0 |
Hepatitis B Virus Infection
[description not available] | 0 | 2.38 | 2 | 0 |
Hepatitis B
INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. | 0 | 7.38 | 2 | 0 |
Chronic Hepatitis
[description not available] | 0 | 6.97 | 1 | 0 |
Hepatitis, Chronic
INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors. | 0 | 1.97 | 1 | 0 |